Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]
Phase 2 trial evaluating everolimus in patients with previously treated unresectable or metastatic esophageal or gastric cancer has complete…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer [Phase 1]
Phase 1 study of TKI 258 in combination with Xeloda (capecitabine) and oxaliplatin in advanced colorectal cancer and gastric cancer was term…
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients
A completed clinical trial evaluating how gastrectomy and reconstruction affect diabetes and hypertension in patients with early gastric can…
-
CLINICAL_TRIALS research · 2016-03-22Clinical Trial Update: The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer [NA]
A clinical trial update examining the feasibility of using an infrared endoscope to diagnose early gastric cancer; the current status is unk…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 study of a modified docetaxel-cisplatin-5-FU regimen with bevacizumab in unresectable or metastatic gastroesophageal adenocarcinoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer [Phase 4]
A Phase 4 study of Herceptin (trastuzumab) in combination with standard chemotherapy for HER2-positive metastatic gastric cancer was termina…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer [Phase 2]
This Phase 2 trial evaluated adding adjuvant intraperitoneal floxuridine to chemoradiation after complete resection in advanced gastric canc…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer. [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating surgery, chemotherapy, and autologous T cell–based immunotherapy for advanced gastric cancer is i…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer [Phase 1]
A Phase 1 clinical trial assesses the safety and preliminary efficacy of AAV-DC-CTL therapy in patients with stage IV gastric cancer.
-
CLINICAL_TRIALS withdrawal · 2016-03-08Clinical Trial Update: Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers [Phase 2]
Phase 2 trial of personalized therapy for esophagogastric cancer using thymidylate synthase genetic markers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection [NA]
Completed clinical trial evaluating whether midazolam premedication improves patient satisfaction after endoscopic submucosal dissection in …
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]
This document reports the completion of a Phase I–II clinical trial evaluating HM781-36B in combination with paclitaxel and trastuzumab for …
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ [Phase 1]
Phase 1/1b trial of rilotumumab in Japanese patients with advanced solid tumors and advanced or metastatic gastric or GEJ cancer has complet…
-
CLINICAL_TRIALS other · 2016-02-23Clinical Trial Update: Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)
A clinical trial update for ONCO-RD 010 CRT indicates the tumor marker study in gastric cancer is suspended.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of ramucirumab in Japanese patients with metastatic gastric or gastroesophageal junction cancer has completed with results pos…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer [Phase 1]
Phase I clinical trial update for CEA-specific AAV-DC-CTL therapy in stage IV gastric cancer. The study is listed as active but not recruiti…
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer [Phase 2]
This clinical trial update covers a Phase 2 study evaluating apatinib plus cytokine-induced killer (CIK) cell therapy as a third-line treatm…
-
FDA approval · 2016-02-18FDA Approved: CAPECITABINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for capecitabine filed by Teva Pharmaceuticals USA, Inc. (ANDA 091649).
-
CLINICAL_TRIALS research · 2016-02-17Clinical Trial Update: Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes
Clinical trial update on digestive tract reconstruction after gastrectomy for gastric cancer in patients with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm
A completed clinical trial evaluated whether serum pepsinogen can predict metachronous gastric neoplasms in patients with gastric cancer. Th…
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Phase 1, Phase 2]
A phase 1/2 trial of Epirubicin (Pharmorubicin), Carboplatin (Paraplatin) and Capecitabine (Xeloda) for unresectable locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Phase 2]
Phase 2 trial assessed docetaxel plus oxaliplatin, with or without cetuximab, in metastatic gastric/GEJ adenocarcinoma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 3]
Amgen's Phase 3 trial evaluating rilotumumab for MET-positive gastric/GEJ adenocarcinoma was terminated, indicating the study did not procee…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers [Phase 2]
A Phase 2 trial of docetaxel in combination with capecitabine for gastric and esophageal cancers was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2016-02-04Clinical Trial Update: Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
This clinical trial update discusses the potential of circulating tumor DNA as a prognostic and predictive biomarker in gastric cancer treat…